Posts By: Karen Jones

Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows

Source Multiple Sclerosis News Today: Inhibition of the neuroactive opioid growth factor (OGF) alters the blood levels of important pro- and anti-inflammatory proteins in mice with multiple sclerosis (MS)-like disease. The recognition of this regulatory response may represent a new way to monitor disease progression and treatment response in MS. These findings were reported in a study published… Read more »